AbSci
Healthcare & Life Sci
Company overview
AbSci uses artificial intelligence to design biologics drugs, combining wet lab work with AI models. Its AI Drug Creation Platform designs differentiated antibodies with 6-week cycle times. AI Target Discovery uses reverse immunology to identify antibodies from super immune responders. The company partners with AstraZeneca, Merck, Caltech, the Bill & Melinda Gates Foundation and others.
Sean McClain founded AbSci in 2011 in Portland, Oregon. The company is now headquartered in Vancouver, Washington, with AI research labs in New York City and Serbia. AbSci is an H-1B sponsor.
- Industry
- Healthcare & Life Sci
- Headquarters
- Vancouver, Canada